TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Nordic Biomarker AB
Closing information (x1000 SEK)
| Closing information | 2023/12 | 2022/12 | 2021/12 (consolidated) |
| Turnover |
122,335
|
129,627
|
130,741 |
| Financial expenses |
2,029
|
1,804
|
391 |
| Earnings before taxes |
-40,723
|
-25,311
|
-10 |
| EBITDA |
-27,102
|
-14,454
|
11,996 |
| Total assets |
163,333
|
208,098
|
173,830 |
| Current assets |
69,278
|
71,014
|
73,201 |
| Current liabilities |
80,304
|
71,158
|
36,838 |
| Equity capital |
75,459
|
135,293
|
99,206 |
| - share capital |
150
|
150
|
150 |
| Employees (average) |
69
|
75
|
66 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 (consolidated) |
| Solvency |
46.2%
|
65.0%
|
57.1% |
| Turnover per employee |
1,773
|
1,728
|
1,981 |
| Profit as a percentage of turnover |
-33.3%
|
-19.5%
|
0.0% |
| Return on assets (ROA) |
-23.7%
|
-11.3%
|
0.2% |
| Current ratio |
86.3%
|
99.8%
|
198.7% |
| Return on equity (ROE) |
-54.0%
|
-18.7%
|
0.0% |
| Change turnover |
-7,292
|
-1,114
|
21,795 |
| Change turnover % | -6% | 20% | |
| Chg. No. of employees |
-6
|
9
|
10 |
| Chg. No. of employees % | -8% | 18% |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 (consolidated) |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.